Comparative Pharmacology
Head-to-head clinical analysis: MIDOL LIQUID GELS versus PARAFON FORTE DSC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MIDOL LIQUID GELS versus PARAFON FORTE DSC.
MIDOL LIQUID GELS vs PARAFON FORTE DSC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Acetaminophen inhibits cyclooxygenase (COX) enzymes in the CNS, reducing prostaglandin synthesis, and elevates pain threshold. Caffeine is a CNS stimulant and adenosine receptor antagonist that enhances analgesic effect. Pyrilamine maleate is an H1-antihistamine with sedative properties. The combination provides analgesic, antipyretic, and antihistaminic effects.
Chlorzoxazone acts on the central nervous system (CNS) at the spinal cord level, possibly by depressing polysynaptic reflexes, producing skeletal muscle relaxation without affecting neuromuscular transmission.
2 capsules orally every 6 hours as needed. Maximum 8 capsules in 24 hours.
Adults: 4 g (500 mg x 8 tablets) orally every 6-8 hours as needed; maximum 8 g (16 tablets) per 24 hours.
None Documented
None Documented
Acetaminophen: 2-3 hours (therapeutic doses); prolonged in overdose (>12 hours) due to saturable metabolism. Caffeine: 3-5 hours (adults).
1-3 hours (terminal); clinically relevant for dosing intervals of 4-6 hours.
Renal elimination: 85-90% as acetaminophen glucuronide and sulfate conjugates; 5-10% unchanged. Biliary/fecal: minimal (<5%).
Primarily renal (85-95% as glucuronide conjugates and unchanged drug; <5% fecal).
Category C
Category C
Analgesic Combination
Muscle Relaxant/Analgesic Combination